Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Trial of Potassium and Acetazolamide in Andersen-Tawil Syndrome

NCT00839501 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT00839501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00839501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Trial of Potassium and Acetazolamide in Andersen-Tawil Syndrome
Lead sponsor
University of Rochester
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2008
Completion date
January 31, 2011
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

andersen-tawil syndrome